Lazard Capital Starts Pharmacyclics (PCYC) at Buy
Tweet
Share
E-mailGet Alerts PCYC Hot Sheet
Price: $261.25 --0%
Rating Summary:
5 Buy, 17 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 5 | New: 35
Rating Summary:
5 Buy, 17 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 5 | New: 35
Join SI Premium – FREE
Lazard Capital initiates coverage on Pharmacyclics (NASDAQ: PCYC) with a Buy. PT $69.00.
For an analyst ratings summary and ratings history on Pharmacyclics click here. For more ratings news on Pharmacyclics click here.
Shares of Pharmacyclics closed at $56.28 yesterday.
For an analyst ratings summary and ratings history on Pharmacyclics click here. For more ratings news on Pharmacyclics click here.
Shares of Pharmacyclics closed at $56.28 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Jefferies Starts Crane NXT (CXT) at Buy, 'Underappreciated Growth and Margin Story'
- RBC Capital Starts Everest Group (EG) at Outperform
- Needham Starts Butterfly Network (BFLY) at Buy
Create E-mail Alert Related Categories
New CoverageRelated Entities
LazardSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
